deItaone on Nostr: REGENERON PHARMACEUTICALS SHARES RESUME TRADING; LAST DOWN 9.5% AFTER U.S. FDA ...
REGENERON PHARMACEUTICALS SHARES RESUME TRADING; LAST DOWN 9.5% AFTER U.S. FDA DECLINES TO APPROVE REGENERON HIGH-DOSE EYLEA
Quoting @DeItaone:
$REGN Halted due to pending news
Published at
2023-06-27 19:17:09Event JSON
{
"id": "f71f8c308d20f0936133b914b0028997cb6ad3bc39ea3ec8330a1059aa8a6759",
"pubkey": "40c1bf5fee3fb2ef7c4fdf114cd0bdee0b8de9346dc2c9e047cf5632369a7141",
"created_at": 1687893429,
"kind": 1,
"tags": [],
"content": "REGENERON PHARMACEUTICALS SHARES RESUME TRADING; LAST DOWN 9.5% AFTER U.S. FDA DECLINES TO APPROVE REGENERON HIGH-DOSE EYLEA\n\nQuoting @DeItaone:\n$REGN Halted due to pending news\n\n",
"sig": "7548846105b0772eba7105b6246051f0819bbabe9541392ef24a51232585d885b0d8369fae2c3dea8a76749c4e079ec83473081a39bb64b942fecd53b95d8770"
}
